Johnson R A, Yeung S M, Stübner D, Bushfield M, Shoshani I
Department of Physiology and Biophysics, State University of New York, Stony Brook 11794-8661.
Mol Pharmacol. 1989 May;35(5):681-8.
The cation and structural requirements of the intracellular inhibitory "P" site of adenylate cyclase were investigated in human platelet membranes, bovine sperm particles, and detergent-solubilized and purified preparations from rat and bovine brain. Sensitivity of adenylate cyclase to P site-mediated inhibition was enhanced by reversible and irreversible activators of the enzyme. The most effective sensitization of the platelet and brain adenylate cyclases was observed with Mn2+ and upon proteolysis with inhibin in the presence of guanosine 5'-O-(3-thiotriphosphate). These resulted in IC50 values for (2',5'dideoxy-adenosine (2',5'-dd-Ado) and 2'-deoxy-3'-AMP of approximately 1-2 microM. The data were consistent with the ideas that P site-mediated inhibition of adenylate cyclase is dependent on divalent cation and is a function of enzyme activity. A number of nucleosides and nucleotides were synthesized and used to define structural requirements for P site-mediated inhibition of a detergent-solubilized adenylate cyclase from rat brain. The data suggest a strict requirement for an intact adenine moiety and a beta-glycosidic linkage for the ribosyl moiety. 2'-Deoxy-and especially 2',5'-dideoxy-ribosyl moieties enhanced sensitivity and a strong preference for phosphate at the 3'-position was exhibited. Substitutions at the 5'-ribose position impaired sensitivity. The order of potency and IC50 values of the more potent adenosine analogs were 2',5'-dideoxy-3'-AMP (congruent to 0.1 microM) greater than 2'-deoxy-3'-AMP (congruent to 1 microM) greater than 2',5'-dd-Ado (congruent to 3 microM) greater than 3'-AMP (congruent to 9 microM) greater than 2'-deoxy-adenosine (congruent to 15 microM) greater than adenosine (congruent to 80 microM). Large substitutions at the 3'-ribose position were tolerated, e.g., dApdN di- and dAp(dN)4 penta-nucleotides and succinyl- and p-fluoro-sulfonyl-benzoyl- moieties. The purified adenylate cyclase from bovine brain was inhibited by P site agonists with IC50 values of 34 and 45 microM for 2'-deoxy-3'-AMP and 2',5'-dd-Ado, respectively. The data imply, first, that the locus of the P site is the catalytic subunit of adenylate cyclase and, second, that the increased sensitivity observed with Mn2+ is due to an effect of the cation on the catalytic subunit. In contrast with adenylate cyclases from other mammalian tissues, the enzyme from bovine sperm exhibited only weak sensitivity to P site agonists; 2'-deoxy-3'-AMP congruent to 2',5'-dd-Ado greater than adenosine, each with IC50 values greater than 1000 microM.(ABSTRACT TRUNCATED AT 400 WORDS)
在人血小板膜、牛精子颗粒以及来自大鼠和牛脑的经去污剂增溶和纯化的制剂中,研究了腺苷酸环化酶细胞内抑制性“P”位点的阳离子和结构要求。腺苷酸环化酶对P位点介导的抑制作用的敏感性可通过该酶的可逆和不可逆激活剂增强。在用锰离子以及在鸟苷5'-O-(3-硫代三磷酸)存在下用抑制素进行蛋白水解时,观察到血小板和脑腺苷酸环化酶最有效的致敏作用。这些导致(2',5'-二脱氧腺苷(2',5'-dd-Ado)和2'-脱氧-3'-AMP的半数抑制浓度(IC50)值约为1 - 2微摩尔。这些数据与以下观点一致,即P位点介导的腺苷酸环化酶抑制作用依赖于二价阳离子,并且是酶活性的函数。合成了许多核苷和核苷酸,并用于确定P位点介导的对大鼠脑去污剂增溶的腺苷酸环化酶抑制作用的结构要求。数据表明对完整的腺嘌呤部分以及核糖部分的β-糖苷键有严格要求。2'-脱氧-尤其是2',5'-二脱氧核糖部分增强了敏感性,并且在3'-位表现出对磷酸根的强烈偏好。5'-核糖位置的取代会损害敏感性。更有效的腺苷类似物的效力顺序和IC50值为2',5'-二脱氧-3'-AMP(约0.1微摩尔)大于2'-脱氧-3'-AMP(约1微摩尔)大于2',5'-dd-Ado(约3微摩尔)大于3'-AMP(约9微摩尔)大于2'-脱氧腺苷(约15微摩尔)大于腺苷(约80微摩尔)。3'-核糖位置的大取代是可以耐受的,例如dApdN二核苷酸和dAp(dN)4五核苷酸以及琥珀酰基和对氟磺酰基苯甲酰基部分。来自牛脑的纯化腺苷酸环化酶被P位点激动剂抑制,2'-脱氧-3'-AMP和2',5'-dd-Ado的IC50值分别为34和45微摩尔。数据表明,首先,P位点的位置是腺苷酸环化酶的催化亚基,其次,用锰离子观察到的敏感性增加是由于阳离子对催化亚基的作用。与其他哺乳动物组织的腺苷酸环化酶不同,来自牛精子的酶对P位点激动剂仅表现出微弱的敏感性;2'-脱氧-3'-AMP约等于2',5'-dd-Ado大于腺苷,它们的IC50值均大于1000微摩尔。(摘要截短于400字)